knowledge -WSS

knowledge

author：Wikipedia 2025-09-03 05:32:48 - browse：51

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： White House launches permanent pandemic office

leisure time

WSS

Dozens dead from Maui wildfires: What we know about the victims

Megan Rapinoe shares emotional post following US Women's World Cup exit

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Indictment alleges Trump's ex

AbbVie dramatically boosts its spending on lobbying

explore

knowledge

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

YouTube cracks down on misinformation on cancer treatment

Sports medicine is finally prioritizing gender equality

Court strikes down limits on filming of police in Arizona

Guidelines to prevent youth baseball injuries need more muscle

Be careful with at

Heart attack and stroke risk calculators need revising

Caitlin Bernard's story shows physicians can't shy from advocacy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

hotspot

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Novo Nordisk touts Wegovy study, but still struggling with supply

Court strikes down limits on filming of police in Arizona

What to know about the judge who will handle the Trump case

CDC backtracks, saying fully vaccinated people can go maskless indoors

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Wikipedia

leisure time

knowledge

explore